Subtopic Deep Dive
Multisystem Inflammatory Syndrome in Children (MIS-C)
Research Guide
What is Multisystem Inflammatory Syndrome in Children (MIS-C)?
Multisystem Inflammatory Syndrome in Children (MIS-C) is a rare hyperinflammatory condition temporally associated with SARS-CoV-2 infection, featuring Kawasaki-like symptoms including fever, rash, mucocutaneous involvement, and potential coronary complications.
MIS-C emerged during the COVID-19 pandemic, presenting with multiorgan involvement and cardiac sequelae resembling Kawasaki disease. Cohort studies report wide clinical spectra from mild inflammation to shock. Over 10 key papers from 2020-2021, including Whittaker et al. (2020, 2015 citations) and Dufort et al. (2020, 1360 citations), describe phenotypes and SARS-CoV-2 antibody correlations.
Why It Matters
MIS-C differentiation from Kawasaki disease informs pediatric protocols during pandemics and vaccine monitoring, as seen in New York State surveillance (Dufort et al., 2020). Cohort analyses reveal treatment responses like IVIG and steroids reduce cardiac sequelae (Feldstein et al., 2021). Understanding immunology aids prognosis, with T-cell activation patterns linked to severity (Consiglio et al., 2020). These insights guide global guidelines for hyperinflammatory pediatric syndromes.
Key Research Challenges
Phenotypic Overlap Differentiation
Distinguishing MIS-C from Kawasaki disease relies on timing with SARS-CoV-2 exposure and antibody levels, but overlaps in rash and coronary aneurysms complicate diagnosis. Whittaker et al. (2020) report 58 cases with variable severity. Toubiana et al. (2020) highlight Paris cohort similarities requiring biomarkers.
Long-term Cardiac Outcomes
Tracking coronary complications post-MIS-C demands longitudinal cohorts amid evolving variants. Feldstein et al. (2021) compare MIS-C to acute COVID-19 outcomes. Godfred-Cato et al. (2020) note US cases with persistent aneurysms.
Immunological Mechanism Elucidation
Unclear antibody-dependent enhancement drives MIS-C pathogenesis despite mild initial COVID-19. Consiglio et al. (2020) detail T-cell and cytokine profiles in 25 patients. Jiang et al. (2020) review global immunology gaps.
Essential Papers
Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2
Elizabeth Whittaker, Alasdair Bamford, Julia Kenny et al. · 2020 · JAMA · 2.0K citations
In this case series of hospitalized children who met criteria for PIMS-TS, there was a wide spectrum of presenting signs and symptoms and disease severity, ranging from fever and inflammation to my...
Multisystem Inflammatory Syndrome in Children in New York State
Elizabeth Dufort, Emilia H. Koumans, Eric J. Chow et al. · 2020 · New England Journal of Medicine · 1.4K citations
The emergence of multisystem inflammatory syndrome in children in New York State coincided with widespread SARS-CoV-2 transmission; this hyperinflammatory syndrome with dermatologic, mucocutaneous,...
Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study
Julie Toubiana, Clément Poirault, Alice Corsia et al. · 2020 · BMJ · 1.1K citations
Abstract Objectives To describe the characteristics of children and adolescents affected by an outbreak of Kawasaki-like multisystem inflammatory syndrome and to evaluate a potential temporal assoc...
The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19
Camila Rosat Consiglio, Nicola Cotugno, Fabian Sardh et al. · 2020 · Cell · 879 citations
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is typically very mild and often asymptomatic in children. A complication is the rare multisystem inflammatory syndrome in chi...
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19
Leora R. Feldstein, Mark W. Tenforde, Kevin G. Friedman et al. · 2021 · JAMA · 835 citations
This case series of patients with MIS-C and with COVID-19 identified patterns of clinical presentation and organ system involvement. These patterns may help differentiate between MIS-C and COVID-19.
COVID-19 and multisystem inflammatory syndrome in children and adolescents
Li Jiang, Kun Tang, Michael Levin et al. · 2020 · The Lancet Infectious Diseases · 818 citations
COVID-19–Associated Multisystem Inflammatory Syndrome in Children — United States, March–July 2020
Shana Godfred‐Cato, Bobbi Bryant, Jessica Leung et al. · 2020 · MMWR Morbidity and Mortality Weekly Report · 782 citations
In April 2020, during the peak of the coronavirus disease 2019 (COVID-19) pandemic in Europe, a cluster of children with hyperinflammatory shock with features similar to Kawasaki disease and toxic ...
Reading Guide
Foundational Papers
No pre-2015 MIS-C papers available; start with Whittaker et al. (2020) for initial case series defining phenotypes.
Recent Advances
Feldstein et al. (2021, JAMA, 835 citations) for US outcomes; Consiglio et al. (2020, Cell, 879 citations) for immunology advances.
Core Methods
Cohort analyses (Dufort et al., 2020), immunological profiling (Consiglio et al., 2020), and systematic reviews (Ahmed et al., 2020) using IVIG/steroid treatments and echocardiography.
How PapersFlow Helps You Research Multisystem Inflammatory Syndrome in Children (MIS-C)
Discover & Search
PapersFlow's Research Agent uses searchPapers and citationGraph to map 10+ high-citation MIS-C papers, starting from Whittaker et al. (2020, JAMA, 2015 citations), revealing clusters around Kawasaki overlaps via findSimilarPapers on Dufort et al. (2020). exaSearch uncovers cohort comparisons like Toubiana et al. (2020).
Analyze & Verify
Analysis Agent employs readPaperContent on Whittaker et al. (2020) to extract phenotypes, then verifyResponse with CoVe checks antibody correlations against Feldstein et al. (2021). runPythonAnalysis processes cohort data for statistical verification of cardiac outcomes (e.g., pandas odds ratios), with GRADE grading for evidence quality in treatment responses.
Synthesize & Write
Synthesis Agent detects gaps in long-term outcomes via contradiction flagging between early cohorts (Godfred-Cato et al., 2020) and immunology (Consiglio et al., 2020); Writing Agent uses latexEditText, latexSyncCitations for Whittaker/Dufort, and latexCompile for protocol manuscripts. exportMermaid visualizes MIS-C vs. Kawasaki flowcharts.
Use Cases
"Analyze survival rates and cardiac sequelae in MIS-C cohorts using Python."
Research Agent → searchPapers('MIS-C cardiac outcomes') → Analysis Agent → readPaperContent(Feldstein 2021) → runPythonAnalysis(pandas survival curves from extracted tables) → matplotlib plot of odds ratios.
"Draft LaTeX review comparing MIS-C and Kawasaki treatments."
Synthesis Agent → gap detection(Whittaker 2020 + Toubiana 2020) → Writing Agent → latexEditText(structured sections) → latexSyncCitations(10 papers) → latexCompile(PDF with coronary diagrams).
"Find code for MIS-C immunological analysis from papers."
Research Agent → paperExtractUrls(Consiglio 2020) → Code Discovery → paperFindGithubRepo → githubRepoInspect(R scripts for T-cell profiling) → runPythonAnalysis(reproduce cytokine stats).
Automated Workflows
Deep Research workflow conducts systematic review of 50+ MIS-C papers via searchPapers → citationGraph → GRADE synthesis, outputting structured reports on phenotypes (e.g., Whittaker et al.). DeepScan applies 7-step analysis with CoVe checkpoints to verify outcomes in Feldstein et al. (2021). Theorizer generates hypotheses on immunology gaps from Consiglio et al. (2020) + Jiang et al. (2020).
Frequently Asked Questions
What defines MIS-C clinically?
MIS-C involves fever, multiorgan inflammation, and SARS-CoV-2 association, per Whittaker et al. (2020) case series of 58 children with Kawasaki-like features and shock.
What methods study MIS-C immunology?
Single-cell RNA-seq and cytokine profiling reveal T-cell activation, as in Consiglio et al. (2020) analysis of 25 MIS-C patients.
What are key MIS-C papers?
Top-cited: Whittaker et al. (2020, JAMA, 2015 citations), Dufort et al. (2020, NEJM, 1360 citations), Toubiana et al. (2020, BMJ, 1121 citations).
What open problems exist in MIS-C?
Long-term coronary risks and variant-specific immunology remain unresolved, with gaps in longitudinal data beyond Godfred-Cato et al. (2020).
Research Kawasaki Disease and Coronary Complications with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Multisystem Inflammatory Syndrome in Children (MIS-C) with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers